FindTrial
Sign In

Thippili Chooranam for Asthma

Pre clinical and clinical evaluation of Thippili chooranam in the management of Iya eraippu Noi - Bronchial Asthma - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103806
Enrollment
61
Registered
2026-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J453- Mild persistent asthma

Interventions

Intervention1: Thippili Chooranam: Dose: 1.5 gms twice daily with honey. Duration: 48 days Route of Administration: per oral

Sponsors

Nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of Bronchial Asthma Age above 18 years to 60 years Both the gender Patients attending OPD at Aringnar Anna Hospital of Indian medicine Chennai

Exclusion criteria

Exclusion criteria: Tuberculosis Bronchietasis Bronchogenic Carcinoma Age belwo 18 and Above 60 Not willing to take part in the study Status Asthmaticus

Design outcomes

Primary

MeasureTime frame
The study is beneficial to patients and also the Siddha practitioners to know about the efficacy of thippili chooranamTimepoint: The total duration of treatment is 48 days or 7 weeks—

Secondary

MeasureTime frame
To know the toxicity and theraputic efficacy of the drug Thippili chooranam was assesed This will provide valuble information about the drugTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr K S Uma

The tamilnadu Dr.M.G.R.Medical University

drumamds@gmail.com9444030333

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026